Back to Top Skip to main content Skip to sub-navigation

Don’t die for the high: Fentanyl kills

Due to the increasing relevance of the drug, the Department of Defense added fentanyl and its metabolite, norfentanyl to all service Drug Demand Reduction Program drug tests. (U.S. Air Force photo by Staff Sgt. Nicole Leidholm) Due to the increasing relevance of the drug, the Department of Defense added fentanyl and its metabolite, norfentanyl to all service Drug Demand Reduction Program drug tests. (U.S. Air Force photo by Staff Sgt. Nicole Leidholm)

Recommended Content:

Substance Abuse

PETERSON AIR FORCE BASE, Colo. — Fentanyl is a synthetic opioid often prescribed to help with severe pain such as during surgical recovery. While it can be very helpful to those who need it, when used outside of the context of recovery, fentanyl can lead to negative consequences to a service member’s health and career.

The National Institute on Drug Abuse states fentanyl works by binding to the body’s opioid receptors, which are found in the areas of the brain that control pain and emotion. What’s different is its strength. Fentanyl is up to 100 times stronger than morphine, which can lead to diminishing sensitivity and increased tolerance, which can lead to creating the feeling of needing more, or addiction.

“Opioid pain relievers are generally safe when taken for a short time and as prescribed by a doctor. But because they produce euphoria in addition to pain relief, they can be misused by taking it in a different way or in a larger quantity than prescribed, or taken without a doctor’s prescription,” said Air Force Lt. Col. Mark Ballesteros, 21st Medical Support Squadron diagnostics and therapeutics flight commander. “Regular use, even when prescribed by a doctor, can lead to dependence and, when misused, opioid pain relievers can lead to addiction, overdose incidents and deaths.”

Synthetic opioids, like fentanyl, are now the most common drugs in drug overdose deaths in the United States. According to the El Paso County Coroner’s report, opioids claimed 78 out of the total 133 drug-related deaths in El Paso County in 2018.

Due to the increasing relevance of the drug, the Department of Defense added fentanyl and its metabolite, norfentanyl to all service Drug Demand Reduction Program drug tests.

“Fentanyl and its metabolite, norfentanyl, have garnered national attention lately because of fentanyl’s growing popularity and potential lethality,” said Navy Lt. Cmdr. Katherine Dozier, Armed Forces Medical Examiner System Special Forensic Toxicology Drug Testing Laboratory chief. “This, combined with the emergence of fentanyl and norfentanyl in SFTDTL’s DoD surveillance testing, led the Office of Drug Demand Reduction to petition for fentanyl’s addition to the standard DDRP drug testing panel.”

While a drug addiction has a negative impact on anyone it effects, it has extra connotations for uniformed service members.

“Wrongful use of controlled substances (to include opioids and opioid derivatives – of which fentanyl is one) is prohibited by Article 112a of the Uniform Code of Military Justice,” said Air Force Maj. James Ferrell, 21st Space Wing judge advocate.” The offense of wrongful use of a controlled substance is punishable by up to five years in confinement and a Dishonorable Discharge.”

Disclaimer: Re-published content may be edited for length and clarity. Read original post.

You also may be interested in...

Avoiding Substance Misuse as a Coping Mechanism

Video
6/23/2021

Military life is rewarding, yet often stressful. Learn five options to help you find healthy ways to cope with stress.

Recommended Content:

Substance Abuse | Psychological Fitness | Real Warriors Campaign

Know the Signs: Preventing Prescription Misuse

Video
6/23/2021

Prescription drug misuse can lead to challenges staying psychologically and physically fit. Learn the warning signs of prescription drug misuse to stay mission ready.

Recommended Content:

Psychological Fitness | Substance Abuse | Real Warriors Campaign

Alcohol Awareness v1

Infographic
3/23/2021
Alcohol Awareness Month social media graphic featuring a black background with a white fold in the left corner an animated man in a suit walking along the base of a teal bottle lying on its side

Alcohol Awareness Month social media graphic featuring a black background with a white fold in the left corner and an animated man in a suit walking along the base of a teal bottle lying on its side

Recommended Content:

April | Substance Abuse

MHS looks to decrease substance abuse, as numbers rose in 2020

Article
1/22/2021
Shadowed image of person sitting at a desk with their head down

Alcohol use remains high in the military, but treatment for substance abuse is evolving.

Recommended Content:

Substance Abuse

What is - Too Much to Lose?

Article
12/15/2020
An open bottle of pills, with some spilling out on the table

Too Much to Lose focuses on preventing prescription drug misuse and illicit and prohibited drug use.

Recommended Content:

Substance Abuse

’Tis the season to be safe and sober – and not a statistic

Article
12/14/2020
Image of a car wreck being towed away

NMRTC Bremerton command leadership recently addressed safety concerns concerning drinking and driving.

Recommended Content:

Substance Abuse

Walter Reed annual symposium focuses on substance use disorder

Article
10/6/2020
Man in lab coat sitting in front of a computer screen

Substance Use Disorder Symposium at WRNMMC looks at its effects, and treatment/prevention within the DoD.

Recommended Content:

Substance Abuse

CBD oil off limits for service members

Article
1/23/2020
A service member checks the label on a supplement. Service members must remain diligent and check labels on consumer products and follow official guidance on CBD products. (U.S. Air Force photo by Staff Sgt. Nicole Leidholm)

The use of CBD products is prohibited for use by service members

Recommended Content:

Armed Forces Medical Examiner System | Substance Abuse

Air Force warns Airmen of e-cigarette risks

Article
12/16/2019
An Airman holds an electronic cigarette at Scott Air Force Base, Illinois. The Centers for Disease Control and Prevention is investigating the more than 2,000 cases of e-cigarette, or vaping, product use associated lung injury that have occurred across the country. (U.S. Air Force photo by Airman 1st Class Erica Crossen)

Many e-cigarette products have a higher concentration of nicotine

Recommended Content:

Substance Abuse | Tobacco-Free Living

DoD adds fentanyl to drug testing panel

Article
11/22/2019
An Airman from the 436th Air Wing inspects a bottle before being asked to provide a urine sample November 8, 2019. The DoD has a zero tolerance policy for the illegal or improper use of drugs by service members. (U.S. Air Force photo by Staff Sgt. Nicole Leidholm)

Fentanyl is an opioid, similar to heroin

Recommended Content:

Substance Abuse | Armed Forces Medical Examiner System

DHA PI 6025.15: Management of Problematic Substance Use by DoD Personnel

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (aa), establishes the Defense Health Agency’s (DHA) procedures to assign responsibilities for problematic alcohol and drug use identification, diagnosis, and treatment for DoD military personnel.

  • Identification #: 6025.15
  • Date: 4/16/2019
  • Type: DHA Procedural Instruction
  • Topics: Substance Abuse

DHA PI 6490.02: Behavioral Health (BH) Treatment and Outcomes Monitoring

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (k): a. Establishes the Defense Health Agency’s (DHA) procedures for the collection and analysis of BH outcome data. b. Addresses how DoD will standardize BH outcome data collection to: assess variations in mental health and substance use care among in-garrison medical treatment facilities (MTFs) and clinics; assess the relationship of treatment protocols and practices to BH outcomes; and identify barriers to provider implementation of evidence-based clinical guidance approved by DoD. c. Designates the Army as the DoD lead Service for maintenance and sustainment of the Behavioral Health Data Portal (BHDP) in specialty care mental health and substance use clinics, referred to collectively as BH clinics, until BHDP functionality can be integrated with GENESIS or another electronic health record (EHR) system managed by DHA. d. Designates DHA Information Operations (J-6) as lead on transitioning BHDP functional requirements related to outcomes monitoring to future EHR data collection platforms and processes.

  • Identification #: DHA PI 6490.02
  • Date: 7/12/2018
  • Type: DHA Procedural Instruction
  • Topics: Substance Abuse

DHA PI 6025.04: Pain Management and Opioid Safety in the MHS

Policy

The purpose of our MHS Pain Management Campaign is to enable Clinical Communities to provide evidence-based pain management guided by clinical practice guidelines (CPGs): effectively treat acute and chronic pain; promote non-pharmacologic treatment; prevent acute pain from becoming chronic; and minimize use of opioids with appropriate prescribing only when indicated. The Pain Management Clinical Support Service achieves these ends through clinical improvements in pain care, clinician and patient education, and research. This Defense Health Agency-Procedural Instruction (DHA-PI) is a dual effort between the Pain Management Clinical Support Service and the Clinical Communities to achieve our stated purpose through implementation of the MHS Stepped Care Model.

DoD Instruction 1010.04: Problematic Substance Use by DoD Personnel

Policy

Establishes policies, assigns responsibilities, and prescribes procedures for problematic alcohol and drug use prevention, identification, diagnosis, and treatment for DoD military and civilian personnel.

  • Identification #: DoD Instruction 1010.04
  • Date: 2/20/2014
  • Type: Instructions
  • Topics: Substance Abuse
Showing results 1 - 14 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.